Lantheus Holdings, Inc vs. Intellia Therapeutics, Inc
Lantheus Holdings, Inc (LNTH) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| LNTH | NTLA | |
|---|---|---|
| Market Cap | $6.56 billion | $1.72 billion |
| Revenue (TTM) | $1.56 billion | $59.51 million |
| Net Income (TTM) | $275.31 million | $-399,975,000 |
LNTH leads on 3 of 3 size & scale factors.
Valuation
| LNTH | NTLA | |
|---|---|---|
| P/E Ratio | 24.27 | — |
| Price / Book | 5.00 | 2.36 |
| Price / Sales | 4.21 | 28.87 |
LNTH and NTLA split the valuation factors evenly.
Profitability
| LNTH | NTLA | |
|---|---|---|
| Net Margin | 17.69% | -672.16% |
| Return on Equity | 20.99% | -54.96% |
LNTH leads on 2 of 2 profitability factors.
Risk & Sentiment
| LNTH | NTLA | |
|---|---|---|
| Short Interest | 0.72% | 2.43% |
LNTH leads on 1 of 1 risk & sentiment factors.
Dig deeper: LNTH overview, LNTH financials, NTLA overview, NTLA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.